Recombinant globulins: novel research tools and possible pharmaceuticals
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 4 (2), 216-219
- https://doi.org/10.1016/0952-7915(92)90017-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and α2–6 sialyltransferase, CD75, on B cellsCell, 1991
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- Mouse LFA‐3 studied with chimeric soluble CD2 shows preferential expression on lymphoid cellsEuropean Journal of Immunology, 1991
- Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.The Journal of Experimental Medicine, 1991
- Recognition by Elam-1 of the Sialyl-Le x Determinant on Myeloid and Tumor CellsScience, 1990
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- Biological properties of a CD4 immunoadhesinNature, 1990
- The Mel 14 antibody binds to the lectin domain of the murine peripheral lymph node homing receptor.The Journal of cell biology, 1990
- Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin moleculesNature, 1989
- Soluble CD4 molecules neutralize human immunodeficiency virus type 1Nature, 1988